tiprankstipranks
pc:wugen

Wugen Inc

Wugen Inc., headquartered in St. Louis, Missouri, specializes in developing off-the-shelf allogeneic CAR-T cell therapies derived from healthy donor cells. The company focuses on addressing unmet needs in hematologic malignancies through its proprietary CAR-T platform, aiming to provide innovative solutions in the field of cancer treatment.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$115M
Total Amount Raised$115M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$115M
Latest Funding Amount$115M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 18, 2025
Investment
$115.00M

Investors

Related News and Analysis